![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Has Healthcare Advanced Synthesis Sa Biasca Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Pyridostigmine bromide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-348 - Rev 04
This Chemical Type CEP, issued on March 01, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1255 associated with this CEP further emphasizes